Acotec Scientific Holdings Limited (7W3) Stock Statistics & Valuation Metrics

Acotec Scientific Holdings Limited has a market cap or net worth of EUR 198.72M. The enterprise value is EUR 1.71B.

Market Cap

EUR 198.72M

Enterprise Value

EUR 1.71B

Acotec Scientific Holdings Limited has 313,389,160 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

313,389,160

Owned by Insiders

―

Owned by Institutions

<0.01%

Acotec Scientific Holdings Limited’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 7.51%.

Return on Equity (ROE)

0.08

Return on Assets (ROA)

0.06

Return on Invested Capital (ROIC)

7.51%

Return on Capital Employed (ROCE)

0.08

Revenue Per Employee

675.01K

Profits Per Employee

124.80K

Employee Count

955

Asset Turnover

0.34

Inventory Turnover

1.33

The current PE Ratio of Acotec Scientific Holdings Limited is -29.60. Acotec Scientific Holdings Limited’s PEG ratio is 0.20.

PE Ratio

-29.60

PS Ratio

2.29

PB Ratio

1.01

Price to FCF

-115.55

Price to Operating Cash Flow

152.08

PEG Ratio

0.20

In the last 12 months, Acotec Scientific Holdings Limited had revenue of 644.63M and earned 119.18M in profits. Earnings per share was 0.39.

Revenue

644.63M

Gross Profit

476.31M

Operating Income

133.15M

Pretax Income

122.18M

Net Income

119.18M

EBITDA

159.45M

Earnings Per Share (EPS)

0.39

In the last 12 months, operating cash flow was 9.31M and capital expenditures -21.71M, giving a free cash flow of -12.40M billion.

Operating Cash Flow

9.31M

Free Cash Flow

-12.40M

Free Cash Flow per Share

-0.04

Acotec Scientific Holdings Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-0.87%

Earnings Yield

-3.55%

Beta

0.66

52-Week Price Change

-53.54%

50-Day Moving Average

0.63

200-Day Moving Average

0.96

Relative Strength Index (RSI)

46.22

Average Volume (3m)

―

Acotec Scientific Holdings Limited upcoming earnings date is Mar 29, 2027, TBA (Not Confirmed).

Last Earnings Date

Aug 31, 2026

Next Earnings Date

Mar 29, 2027

Ex-Dividend Date

―

Acotec Scientific Holdings Limited as a current ratio of 5.73, with Debt / Equity ratio of 16.56%

Current Ratio

5.73

Quick Ratio

5.19

Debt to Market Cap

0.02

Net Debt to EBITDA

-0.98

Interest Coverage Ratio

14.19

In the past 12 months, Acotec Scientific Holdings Limited has paid 3.00M in taxes.

Income Tax

3.00M

Effective Tax Rate

0.02

Acotec Scientific Holdings Limited EV to EBITDA ratio is -137.70, with an EV/FCF ratio of -124.43.

EV to Sales

2.47

EV to EBITDA

-137.70

EV to Free Cash Flow

-124.43

EV to Operating Cash Flow

165.66

Acotec Scientific Holdings Limited has EUR 806.80M in cash and marketable securities with EUR 193.70M in debt, giving a net cash position of EUR 613.11M billion.

Cash & Marketable Securities

EUR 806.80M

Total Debt

EUR 193.70M

Net Cash

EUR 613.11M

Net Cash Per Share

EUR 1.96

Tangible Book Value Per Share

EUR 4.63

Gross margin is 71.84%, with operating margin of -5.96%, and net profit margin of -8.04%.

Gross Margin

71.84%

Operating Margin

-5.96%

Pretax Margin

-7.66%

Net Profit Margin

-8.04%

EBITDA Margin

-1.79%

EBIT Margin

-7.95%

The average price target for Acotec Scientific Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

1.73%

EPS Growth Forecast

-149.76%